Interaction Between the Brain Hemispheres - Key to Motor Recovery After Stroke

NCT ID: NCT06381388

Last Updated: 2025-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-11

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rationale: Acute stroke leaves many patients with functional deficits, of which upper extremity motor impairment is one of the most disabling. Evidence from imaging and electrophysiological studies converge on the idea that impaired motor function after stroke is associated with disrupted network activity in the brain. Non-invasive brain stimulation methods, like transcranial magnetic stimulation (TMS), can be used to restore disrupted network activity and have been shown to successfully facilitate recovery of motor function in patients with stroke. Application of continuous theta burst stimulation (cTBS), an inhibitory form of TMS, to the contralesional motor cortex has been shown to improve the recovery of motor function in patients with stroke. However, responsiveness to this treatment varies considerably between stroke patients and the mechanisms through which contralesional cTBS facilitates recovery of motor function remain unclear.

Objective: To determine if contralesional cTBS normalizes interhemispheric inhibition from the contralesional to ipsilesional primary motor cortex stroke patients with motor impairments. Age-matched healthy persons will serve as controls.

Study design: A prospective, open-label within-subject intervention study

Study population: 40 patients with first-ever ischemic stroke in one hemisphere and a unilateral paresis of the upper extremity, and 40 age-matched controls.

Main endpoints: Primary endpoint: Interhemispheric inhibition from the contralesional to ipsilesional primary motor cortex. Secondary endpoints: contralesional intracortical inhibition; effect of contralesional TMS interference on finger tapping frequency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active cTBS

cTBS delivered with an active TMS coil

Group Type EXPERIMENTAL

cTBS

Intervention Type DEVICE

A single cTBS session delivered to the contralesional primary motor cortex.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cTBS

A single cTBS session delivered to the contralesional primary motor cortex.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years;
* First-ever ischemic stroke or intracerebral hemorrhage in a cerebral hemisphere or the brainstem;
* Unilateral paresis of an upper extremity with a Motricity Index (MI) between 9 and 99
* Inclusion possible between 3 weeks and 6 weeks after stroke onset;
* Signed informed consent.


* Age ≥ 18 years;
* Signed informed consent.
* Normal motor function with a minimum Motricity Index (MI) of 99.

Exclusion Criteria

* Disabling medical conditions (severe heart disease, severe head trauma, severe mental illness);
* Severe deficits in communication, memory or understanding which could impede participation, as determined by the treating physician;
* Contraindications to TMS and/or MRI (ferrous implants, history of epilepsy, drug or alcohol abuse over a period of 6 months prior to the experiment, pregnancy);
* Life expectancy shorter than one year;
* Upper limb paresis prior to stroke onset.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jord Vink

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jord Vink

Coordinating investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

De Hoogstraat Revalidatie

Utrecht, Utrecht, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jord Vink, PhD

Role: CONTACT

+31634959811

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne Visser-Meily, MD, PhD

Role: primary

+31 88 75 588 31

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL86587.041.24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post Stroke Motor Learning
NCT01519843 SUSPENDED NA